DiaMedica Therapeutics
DMAC
DMAC
23 hedge funds and large institutions have $21M invested in DiaMedica Therapeutics in 2020 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
Holders
23
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.4M | |
| 2 | +$578K | |
| 3 | +$547K | |
| 4 |
Bank of New York Mellon
New York
|
+$93K |
| 5 |
BlackRock
New York
|
+$42.6K |
Top Sellers
| 1 | -$1.09M | |
| 2 | -$296K | |
| 3 | -$53.7K | |
| 4 |
Millennium Management
New York
|
-$30K |
| 5 |
PFGIA
Patriot Financial Group Insurance Agency
Westborough,
Massachusetts
|
-$8K |